Cerebral angiography with iohexol. A comparison with metrizamide in man.
The new non-ionic contrast medium iohexol was compared with Amipaque in selective cerebral angiography in a double blind study in 60 patients. There were no adverse reactions or reports of discomfort during the examinations or in the 24 h follow-up period. No differences were observed with regard to image quality or cerebral circulation time.
D000328:Adult; D000368:Aged; D002533:Cerebral Angiography; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007463:Iodobenzoates / Q000009:adverse effects; D007472:Iohexol; D008297:Male; D008793:Metrizamide / Q000009:adverse effects; D008875:Middle Aged; D014283:Triiodobenzoic Acids / Q000009:adverse effects
D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D007472:Iohexol; D008793:Metrizamide